| David A Rutherford, DO | |
|
200 Exempla Cir, Lafayette, CO 80026-3370 | |
| (303) 689-4000 | |
| (303) 467-8894 |
| Full Name | David A Rutherford |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 21 Years |
| Location | 200 Exempla Cir, Lafayette, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750318622 | NPI | - | NPPES |
| 64079538 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 34-008680 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lutheran Medical Center | Wheat ridge, CO | Hospital |
| Good Samaritan Medical Center Llc | Lafayette, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usacs Community Emergency Services Of Colorado Inc. | 2466711536 | 169 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.
Rates of serious injury among child pedestrians in poor areas of England are four times as high as those among children in affluent areas, finds research published ahead of print in the Archives of Disease in Childhood.
Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from Duchenne patients.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
Among postmenopausal women with normal body mass index, those with higher body fat levels had an increased risk for invasive breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27-30.
› Verified 3 days ago
| Entity Name | Usacs Of Colorado Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760415871 PECOS PAC ID: 4981507571 Enrollment ID: O20040130000439 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.
Rates of serious injury among child pedestrians in poor areas of England are four times as high as those among children in affluent areas, finds research published ahead of print in the Archives of Disease in Childhood.
Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from Duchenne patients.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
Among postmenopausal women with normal body mass index, those with higher body fat levels had an increased risk for invasive breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27-30.
› Verified 3 days ago
| Entity Name | Emergency Service Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326097668 PECOS PAC ID: 1557255882 Enrollment ID: O20040209001037 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.
Rates of serious injury among child pedestrians in poor areas of England are four times as high as those among children in affluent areas, finds research published ahead of print in the Archives of Disease in Childhood.
Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from Duchenne patients.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
Among postmenopausal women with normal body mass index, those with higher body fat levels had an increased risk for invasive breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27-30.
› Verified 3 days ago
| Entity Name | Usacs Community Emergency Services Of Colorado Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053824979 PECOS PAC ID: 2466711536 Enrollment ID: O20180117002329 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.
Rates of serious injury among child pedestrians in poor areas of England are four times as high as those among children in affluent areas, finds research published ahead of print in the Archives of Disease in Childhood.
Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from Duchenne patients.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
Among postmenopausal women with normal body mass index, those with higher body fat levels had an increased risk for invasive breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27-30.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David A Rutherford, DO Dept 1265, Denver, CO 80256-0001 Ph: (866) 898-7136 | David A Rutherford, DO 200 Exempla Cir, Lafayette, CO 80026-3370 Ph: (303) 689-4000 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.
Rates of serious injury among child pedestrians in poor areas of England are four times as high as those among children in affluent areas, finds research published ahead of print in the Archives of Disease in Childhood.
Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from Duchenne patients.
Johnson & Johnson Pharmaceutical Research & Development, LLC (J&JPRD) announced that health authorities are reviewing scientific data from two clinical trials evaluating an investigational use of the company's Alzheimer's treatment, Reminyl (galantamine hydrobromide), in individuals with mild cognitive impairment.
Among postmenopausal women with normal body mass index, those with higher body fat levels had an increased risk for invasive breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27-30.
› Verified 3 days ago
Evan Lynell Green, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-689-4000 | |
Jeffrey William Rickard, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-689-4444 | |
Jordan Elizabeth Ancmon, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-689-4000 | |
Douglas Spencer, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-689-4000 | |
Dr. Ralph William Hart, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 W South Boulder Rd, Lafayette, CO 80026 Phone: 303-666-4357 Fax: 303-604-5058 | |
Rebecca Higbee, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 303-689-4444 | |
Dr. Kelli Ann Cleary, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Exempla Cir, Lafayette, CO 80026 Phone: 866-898-7136 Fax: 616-975-9827 |